Lista ta' Kandidati ta' sustanzi ta' tħassib serju ħafna għall-Awtorizzazzjoni
Lista ta' Kandidati ta' sustanzi ta' tħassib serju ħafna għall-Awtorizzazzjoni
(ippubblikata b'konformità mal-Artikolu 59(10) tar-Regolament REACH)
Lista ta' Kandidati ta' sustanzi ta' tħassib serju ħafna għall-Awtorizzazzjoni
Noti:
- Verżjoni awtentika: Il-Lista tal-Kandidati ppubblikata fuq dan is-sit web biss hija meqjusa awtentika. Il-kumpaniji jistgħu jkollhom obbligi legali immedjati wara l-inklużjoni ta’ sustanza fil-Lista tal-Kandidati fuq dan is-sit web inkluż b’mod partikolari l-Artikoli 7, 31 u 33 tar-Regolament REACH.
- Identifikaturi numeriċi: Kull entrata fil-lista tal-kandidati tkopri kemm forom anidri kif ukoll dawk idrati ta’ sustanza. In-numru CAS muri f’entrata huwa tipikament għall-forma anidra. Forom idrati tas-sustanza identifikati minn numri CAS oħra għadhom jaqgħu fil-kamp tal-applikazzjoni tal-entrata.
- Identifikaturi numeriċi oħra: Għal dawk l-entrati b’“-” fil-kolonni tan-numri EC u tan-numri CAS, inventarju mhux eżawrjenti tan-numri tar-Reġistru EC u/jew dak CAS li jiddeskrivi sustanzi jew gruppi tas-sustanzi kkunsidrati li jaqgħu fil-kamp tal-applikazzjoni tal-entrata fil-Lista tal-Kandidati huwa inkluż, fejn prattikament possibbli. Din l-informazzjoni tista’ tiġi aċċessata permezz tal-buttuna “Dettalji” tal-entrata magħżula.
Filter the list
The List does not contain any Substances.
Deċiżjoni | Stal-IUCLID | ||||||
---|---|---|---|---|---|---|---|
show/hide
(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one
Nru KE:
253-242-6
| Nru CAS:
36861-47-9
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nru KE:
-
| Nru CAS:
1782069-81-1
(1R,3E,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nru KE:
-
| Nru CAS:
95342-41-9
(1S,3E,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nru KE:
-
| Nru CAS:
852541-30-1
(1R,3Z,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nru KE:
-
| Nru CAS:
852541-21-0
(1R,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nru KE:
-
| Nru CAS:
741687-98-9
(1S,3Z,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
Nru KE:
-
| Nru CAS:
852541-25-4
|
-
|
-
|
17-Jan-2022
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
Nru KE:
272-013-1
| Nru CAS:
68648-93-1
|
-
|
-
|
15-Ġun-2015
|
Toxic for reproduction (Article 57c) |
Details | ||
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
Nru KE:
-
| Nru CAS:
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
Nru KE:
-
| Nru CAS:
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
Nru KE:
236-948-9
| Nru CAS:
13560-89-9
|
-
|
-
|
15-Jan-2018
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
08-Lul-2021
|
Carcinogenic (Article 57a) |
Details | ||
covering any of their individual isomers and combinations thereof
show/hide
potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate
Nru KE:
266-578-3
| Nru CAS:
67118-55-2
|
-
|
-
|
16-Lul-2019
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
show/hide
|
-
|
-
|
08-Lul-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
|
-
|
-
|
19-Diċ-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | ||
covering well-defined substances and UVCB substances, polymers and homologues
show/hide
Poly(oxy-1,2-ethanediyl), α-[(1,1,3,3-tetramethylbutyl)phenyl]-ω-hydroxy-
Nru KE:
-
| Nru CAS:
9036-19-5
20-[4-(1,1,3,3-tetramethylbutyl)phenoxy]-3,6,9,12,15,18-hexaoxaicosan-1-ol
Nru KE:
219-682-8
| Nru CAS:
2497-59-8
|
-
|
-
|
19-Diċ-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
12-Jan-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
show/hide
|
-
|
-
|
19-Diċ-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
covering any of the individual stereoisomers of [1] and [2] or any combination thereof
show/hide
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nru KE:
-
| Nru CAS:
676367-06-9
Reaction mass of 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
Nru KE:
413-720-9
| Nru CAS:
-
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
Nru KE:
-
| Nru CAS:
117933-89-8
1,3-Dioxane, 2-(2,4-dimethyl-3-cyclohexen-1-yl)-5-methyl-5-(1-methylpropyl)-
Nru KE:
-
| Nru CAS:
186309-28-4
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nru KE:
-
| Nru CAS:
676367-05-8
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-rel-
Nru KE:
-
| Nru CAS:
343934-04-3
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nru KE:
-
| Nru CAS:
676367-09-2
1,3-Dioxane, 2-[(1R,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-rel-
Nru KE:
-
| Nru CAS:
343934-05-4
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nru KE:
-
| Nru CAS:
676367-04-7
1,3-Dioxane, 2-[(1R,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nru KE:
-
| Nru CAS:
676367-08-1
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nru KE:
-
| Nru CAS:
676367-03-6
1,3-Dioxane, 2-[(1S,2R)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, trans-
Nru KE:
-
| Nru CAS:
676367-07-0
1,3-Dioxane, 2-[(1S,2S)-2,4-dimethyl-3-cyclohexen-1-yl]-5-methyl-5-(1-methylpropyl)-, cis-
Nru KE:
-
| Nru CAS:
676367-02-5
|
-
|
-
|
15-Ġun-2015
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
15-Diċ-2010
|
Carcinogenic (Article 57a) |
Details | ||
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium and silicon are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm) c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
19-Diċ-2011
|
Carcinogenic (Article 57a) |
Details | ||
show/hide
|
-
|
-
|
17-Jan-2023
|
vPvB (Article 57e) |
Details | ||
EC No. 233-139-2 and EC No. 234-343-4
show/hide
|
-
|
-
|
18-Ġun-2010
|
Toxic for reproduction (Article 57c) |
Details | ||
all possible combinations of the cis- and trans-isomers
show/hide
|
-
|
-
|
19-Diċ-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
show/hide
|
-
|
-
|
19-Jan-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
and all major diastereoisomers identified
show/hide
|
-
|
-
|
28-Ott-2008
|
PBT (Article 57d) |
Details | ||
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
show/hide
|
-
|
-
|
19-Diċ-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
Details | ||
UVCB substances consisting of more than or equal to 80% linear chloroalkanes with carbon chain lengths within the range from C14 to C17
show/hide
|
-
|
-
|
08-Lul-2021
|
PBT (Article 57d) vPvB (Article 57e) |
Details | ||
-
|
776297-69-9
|
19-Diċ-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
show/hide
|
-
|
-
|
12-Jan-2017
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
show/hide
|
-
|
-
|
08-Lul-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
1-(4-butoxy-1-naphthalenyl)tetrahydrothiophenium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfonate
Nru KE:
468-770-4
| Nru CAS:
-
N,N,N-triethylethanaminium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
Nru KE:
-
| Nru CAS:
25628-08-4
|
-
|
-
|
16-Jan-2020
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
show/hide
|
-
|
-
|
17-Jan-2023
|
Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
PFHxS
show/hide
tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1)
Nru KE:
274-462-9
| Nru CAS:
70225-16-0
Phosphonium, triphenyl(phenylmethyl)-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
1000597-52-3
Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
1310480-24-0
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
1310480-27-3
Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(phenylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
1310480-28-4
Beta-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
Nru KE:
-
| Nru CAS:
1329995-45-0
Gamma-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1)
Nru KE:
-
| Nru CAS:
1329995-69-8
Sulfonium, triphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
144116-10-9
Quinolinium, 1-(carboxymethyl)-4-[2-[4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydrocyclopent[b]indol-7-yl]ethenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
1462414-59-0
Iodonium, diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
153443-35-7
Methanaminium, N,N,N-trimethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1)
Nru KE:
-
| Nru CAS:
189274-31-5
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd.with 2-methyl-2-propanamine (1:1)
Nru KE:
-
| Nru CAS:
202189-84-2
Iodonium, bis[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
213740-81-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, gallium salt (9CI)
Nru KE:
-
| Nru CAS:
341035-71-0
Sulfonium, bis(4-methylphenyl)phenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
341548-85-4
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, scandium(3+) salt (3:1)
Nru KE:
-
| Nru CAS:
350836-93-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, neodymium(3+) salt (3:1)
Nru KE:
-
| Nru CAS:
41184-65-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, yttrium(3+) salt (3:1)
Nru KE:
-
| Nru CAS:
41242-12-0
Sulfonium, (thiodi-4,1-phenylene)bis[diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:2)
Nru KE:
-
| Nru CAS:
421555-73-9
Iodonium, bis[4-(1,1-dimethylpropyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic
Nru KE:
-
| Nru CAS:
421555-74-0
Sulfonium, tris[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
425670-70-8
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, lithium salt (1:1)
Nru KE:
-
| Nru CAS:
55120-77-9
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt
Nru KE:
-
| Nru CAS:
70136-72-0
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with N,N-diethylethanamine (1:1)
Nru KE:
-
| Nru CAS:
72033-41-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, sodium salt
Nru KE:
-
| Nru CAS:
82382-12-5
Iodonium, bis[(1,1-dimethylethyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) (9CI)
Nru KE:
-
| Nru CAS:
866621-50-3
Sulfonium, (4-methylphenyl)diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
910606-39-2
Sulfonium, [4-[(2-methyl-1-oxo-2-propen-1-yl)oxy]phenyl]diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
911027-68-4
Dibenzo[k,n][1,4,7,10,13]tetraoxathiacyclopentadecinium, 19-[4-(1,1-dimethylethyl)phenyl]-6,7,9,10,12,13-hexahydro-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1)
Nru KE:
-
| Nru CAS:
928049-42-7
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, cesium salt (1:1)
Nru KE:
-
| Nru CAS:
92011-17-1
1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. With pyrrolidine (1:1)
Nru KE:
-
| Nru CAS:
1187817-57-7
|
-
|
-
|
07-Lul-2017
|
vPvB (Article 57e) |
Details | ||
show/hide
|
-
|
-
|
17-Diċ-2015
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | ||
show/hide
|
-
|
-
|
08-Lul-2021
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
-
|
-
|
17-Diċ-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
Nru KE:
-
| Nru CAS:
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
Nru KE:
300-298-5
| Nru CAS:
93925-00-9
|
-
|
-
|
15-Jan-2018
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
show/hide
Borate(2-), tetrahydroxybis[μ-(peroxy-κO1:κO2)]di-, sodium, hydrate (1:2:6)
Nru KE:
-
| Nru CAS:
125022-34-6
|
-
|
-
|
16-Ġun-2014
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
|
-
|
-
|
16-Lul-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium, silicon and zirconium are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm). c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight
show/hide
|
-
|
-
|
19-Diċ-2011
|
Carcinogenic (Article 57a) |
Details | ||
200-028-5
|
50-32-8
|
20-Ġun-2016
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Toxic for reproduction (Article 57c) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
200-268-0
|
56-35-9
|
28-Ott-2008
|
PBT (Article 57d) |
Details | |||
200-280-6
|
56-55-3
|
15-Jan-2018
|
Carcinogenic (Article 57a) PBT (Article 57d) vPvB (Article 57e) |
Details | |||
200-453-6
|
60-09-3
|
19-Diċ-2012
|
Carcinogenic (Article 57a) |
Details | |||
200-589-6
|
64-67-5
|
19-Diċ-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
200-679-5
|
68-12-2
|
19-Diċ-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
200-755-8
|
71-48-7
|
15-Diċ-2010
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
200-842-0
|
75-12-7
|
18-Ġun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
200-879-2
|
75-56-9
|
19-Diċ-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
201-004-7
|
77-09-8
|
19-Diċ-2011
|
Carcinogenic (Article 57a) |
Details | |||
201-025-1
|
77-40-7
|
08-Lul-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
201-058-1
|
77-78-1
|
19-Diċ-2012
|
Carcinogenic (Article 57a) |
Details | |||
201-075-4
|
78-00-2
|
19-Diċ-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-167-4
|
79-01-6
|
18-Ġun-2010
|
Carcinogenic (Article 57a) |
Details | |||
201-173-7
|
79-06-1
|
30-Mar-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
Details | |||
201-182-6
|
79-16-3
|
19-Diċ-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
201-236-9
|
79-94-7
|
17-Jan-2023
|
Carcinogenic (Article 57a) |
Details | |||